These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 27013134)

  • 21. Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.
    Serre SB; Jensen SB; Ghanem L; Humes DG; Ramirez S; Li YP; Krarup H; Bukh J; Gottwein JM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3563-78. PubMed ID: 27021330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment.
    Bagaglio S; Andolina A; Merli M; Uberti-Foppa C; Morsica G
    Viruses; 2016 Mar; 8(4):91. PubMed ID: 27023593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular Relocalization.
    Valero ML; Sabariegos R; Cimas FJ; Perales C; Domingo E; Sánchez-Prieto R; Mas A
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3540-50. PubMed ID: 27021315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis.
    Ejaz S; Paracha RZ; Ejaz S; Jamal Z
    PLoS One; 2023; 18(9):e0291213. PubMed ID: 37682810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles.
    Hanafy MS; Dao HM; Xu H; Koleng JJ; Sakran W; Cui Z
    Int J Pharm X; 2023 Dec; 6():100197. PubMed ID: 37521246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure and function of protein kinase C-related kinases (PRKs).
    Sophocleous G; Owen D; Mott HR
    Biochem Soc Trans; 2021 Feb; 49(1):217-235. PubMed ID: 33522581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnology for virus treatment.
    Zhou J; Krishnan N; Jiang Y; Fang RH; Zhang L
    Nano Today; 2021 Feb; 36():101031. PubMed ID: 33519948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in siRNA delivery mediated by lipid-based nanoparticles.
    Yonezawa S; Koide H; Asai T
    Adv Drug Deliv Rev; 2020; 154-155():64-78. PubMed ID: 32768564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid nanoparticle technology for therapeutic gene regulation in the liver.
    Witzigmann D; Kulkarni JA; Leung J; Chen S; Cullis PR; van der Meel R
    Adv Drug Deliv Rev; 2020; 159():344-363. PubMed ID: 32622021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice.
    Lee SH; Moon JS; Pak BY; Kim GW; Lee W; Cho H; Kim S; Kim SJ; Oh JW
    Sci Rep; 2018 Aug; 8(1):12469. PubMed ID: 30127498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity.
    Lee W; Lee SH; Kim M; Moon JS; Kim GW; Jung HG; Kim IH; Oh JE; Jung HE; Lee HK; Ku KB; Ahn DG; Kim SJ; Kim KS; Oh JW
    Nat Commun; 2018 Apr; 9(1):1606. PubMed ID: 29686409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nanotechnology in the treatment of viral infections.
    Singh L; Kruger HG; Maguire GEM; Govender T; Parboosing R
    Ther Adv Infect Dis; 2017 Jul; 4(4):105-131. PubMed ID: 28748089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Nanomaterials for Gene Delivery-A Review.
    Riley MK; Vermerris W
    Nanomaterials (Basel); 2017 Apr; 7(5):. PubMed ID: 28452950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.
    Kim SJ; Kim JH; Kim YG; Lim HS; Oh JW
    J Biol Chem; 2004 Nov; 279(48):50031-41. PubMed ID: 15364941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    Moon JS; Lee SH; Kim EJ; Cho H; Lee W; Kim GW; Park HJ; Cho SW; Lee C; Oh JW
    PLoS One; 2016; 11(1):e0146710. PubMed ID: 26751678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
    Halfon P; Sarrazin C
    Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2.
    Moon JS; Lee SH; Han SH; Kim EJ; Cho H; Lee W; Kim MK; Kim TE; Park HJ; Rhee JK; Kim SJ; Cho SW; Han SH; Oh JW
    Nanomedicine; 2016 Aug; 12(6):1489-98. PubMed ID: 27013134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.